pubmed-article:16219141 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16219141 | lifeskim:mentions | umls-concept:C0149543 | lld:lifeskim |
pubmed-article:16219141 | lifeskim:mentions | umls-concept:C0178602 | lld:lifeskim |
pubmed-article:16219141 | lifeskim:mentions | umls-concept:C2931822 | lld:lifeskim |
pubmed-article:16219141 | lifeskim:mentions | umls-concept:C0034897 | lld:lifeskim |
pubmed-article:16219141 | lifeskim:mentions | umls-concept:C1306673 | lld:lifeskim |
pubmed-article:16219141 | lifeskim:mentions | umls-concept:C1511253 | lld:lifeskim |
pubmed-article:16219141 | pubmed:issue | 10 | lld:pubmed |
pubmed-article:16219141 | pubmed:dateCreated | 2005-10-12 | lld:pubmed |
pubmed-article:16219141 | pubmed:abstractText | The recurrence rate in skull base is high for nasopharyngeal carcinoma (NPC) patients with cavernous sinus or/and sphenoid sinus involvement. This study was conducted to explore the impact of dose boost in skull base on the recurrence in skull base and survival of NPC patients with cavernous sinus or/and sphenoid sinus involvement. | lld:pubmed |
pubmed-article:16219141 | pubmed:language | chi | lld:pubmed |
pubmed-article:16219141 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16219141 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16219141 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16219141 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16219141 | pubmed:month | Oct | lld:pubmed |
pubmed-article:16219141 | pubmed:issn | 1000-467X | lld:pubmed |
pubmed-article:16219141 | pubmed:author | pubmed-author:YinLiL | lld:pubmed |
pubmed-article:16219141 | pubmed:author | pubmed-author:HuangPei-YuPY | lld:pubmed |
pubmed-article:16219141 | pubmed:author | pubmed-author:CaoKa-JiaKJ | lld:pubmed |
pubmed-article:16219141 | pubmed:author | pubmed-author:XieGuo-FengGF | lld:pubmed |
pubmed-article:16219141 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16219141 | pubmed:volume | 24 | lld:pubmed |
pubmed-article:16219141 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16219141 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16219141 | pubmed:pagination | 1246-8 | lld:pubmed |
pubmed-article:16219141 | pubmed:meshHeading | pubmed-meshheading:16219141... | lld:pubmed |
pubmed-article:16219141 | pubmed:meshHeading | pubmed-meshheading:16219141... | lld:pubmed |
pubmed-article:16219141 | pubmed:meshHeading | pubmed-meshheading:16219141... | lld:pubmed |
pubmed-article:16219141 | pubmed:meshHeading | pubmed-meshheading:16219141... | lld:pubmed |
pubmed-article:16219141 | pubmed:meshHeading | pubmed-meshheading:16219141... | lld:pubmed |
pubmed-article:16219141 | pubmed:meshHeading | pubmed-meshheading:16219141... | lld:pubmed |
pubmed-article:16219141 | pubmed:meshHeading | pubmed-meshheading:16219141... | lld:pubmed |
pubmed-article:16219141 | pubmed:meshHeading | pubmed-meshheading:16219141... | lld:pubmed |
pubmed-article:16219141 | pubmed:meshHeading | pubmed-meshheading:16219141... | lld:pubmed |
pubmed-article:16219141 | pubmed:meshHeading | pubmed-meshheading:16219141... | lld:pubmed |
pubmed-article:16219141 | pubmed:meshHeading | pubmed-meshheading:16219141... | lld:pubmed |
pubmed-article:16219141 | pubmed:meshHeading | pubmed-meshheading:16219141... | lld:pubmed |
pubmed-article:16219141 | pubmed:meshHeading | pubmed-meshheading:16219141... | lld:pubmed |
pubmed-article:16219141 | pubmed:meshHeading | pubmed-meshheading:16219141... | lld:pubmed |
pubmed-article:16219141 | pubmed:meshHeading | pubmed-meshheading:16219141... | lld:pubmed |
pubmed-article:16219141 | pubmed:meshHeading | pubmed-meshheading:16219141... | lld:pubmed |
pubmed-article:16219141 | pubmed:meshHeading | pubmed-meshheading:16219141... | lld:pubmed |
pubmed-article:16219141 | pubmed:meshHeading | pubmed-meshheading:16219141... | lld:pubmed |
pubmed-article:16219141 | pubmed:year | 2005 | lld:pubmed |
pubmed-article:16219141 | pubmed:articleTitle | [Impact of dose boost in skull base on recurrence of stage T4 nasopharyngeal carcinoma]. | lld:pubmed |
pubmed-article:16219141 | pubmed:affiliation | Key Laboratory of Oncology in Southern China, Guangzhou, Guangdong, P. R. China. | lld:pubmed |
pubmed-article:16219141 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16219141 | pubmed:publicationType | English Abstract | lld:pubmed |